
### [NCIT:C3363](http://purl.obolibrary.org/obo/NCIT_C3363)
**Label:** Sebaceous Gland Neoplasm

**Subclasses:** [NCIT:C8409](http://purl.obolibrary.org/obo/NCIT_C8409) (Malignant Sebaceous Neoplasm), [NCIT:C40310](http://purl.obolibrary.org/obo/NCIT_C40310) (Sebaceous Carcinoma), [NCIT:C134831](http://purl.obolibrary.org/obo/NCIT_C134831) (Eyelid Sebaceous Gland Carcinoma), [NCIT:C43340](http://purl.obolibrary.org/obo/NCIT_C43340) (Ocular Sebaceous Carcinoma), [NCIT:C8525](http://purl.obolibrary.org/obo/NCIT_C8525) (Benign Sebaceous Neoplasm), [NCIT:C43341](http://purl.obolibrary.org/obo/NCIT_C43341) (Extraocular Cutaneous Sebaceous Carcinoma), [NCIT:C40309](http://purl.obolibrary.org/obo/NCIT_C40309) (Vulvar Sebaceous Carcinoma), [NCIT:C43336](http://purl.obolibrary.org/obo/NCIT_C43336) (Sebaceoma), [NCIT:C40369](http://purl.obolibrary.org/obo/NCIT_C40369) (Sebaceous Breast Carcinoma), [NCIT:C4174](http://purl.obolibrary.org/obo/NCIT_C4174) (Sebaceous Adenoma), 

**Class expressions from DL-Learner:**

- [UBERON:0002330](http://purl.obolibrary.org/obo/UBERON_0002330) (exocrine system) 57.14%
- [UBERON:0002097](http://purl.obolibrary.org/obo/UBERON_0002097) (skin of body) 57.14%
- [CL:2000021](http://purl.obolibrary.org/obo/CL_2000021) (sebaceous gland native cell) 57.14%
- [CL:0000317](http://purl.obolibrary.org/obo/CL_0000317) (sebum secreting cell) 57.14%
- [CL:0000152](http://purl.obolibrary.org/obo/CL_0000152) (exocrine cell) 57.14%
- Thing 52.12%
- [UBERON:0001821](http://purl.obolibrary.org/obo/UBERON_0001821) (sebaceous gland) 42.50%
- [UBERON:0001821](http://purl.obolibrary.org/obo/UBERON_0001821) (sebaceous gland) and (not ([NCIT:C134745](http://purl.obolibrary.org/obo/NCIT_C134745) (Stage I Hilar Cholangiocarcinoma AJCC v8))) 42.50%
- [UBERON:0001821](http://purl.obolibrary.org/obo/UBERON_0001821) (sebaceous gland) and (not ([NCIT:C134744](http://purl.obolibrary.org/obo/NCIT_C134744) (Stage 0 Hilar Cholangiocarcinoma AJCC v8))) 42.50%
- [UBERON:0001821](http://purl.obolibrary.org/obo/UBERON_0001821) (sebaceous gland) and (not ([NCIT:C134675](http://purl.obolibrary.org/obo/NCIT_C134675) (Stage IV Gallbladder Cancer AJCC v8))) 42.50%
- [UBERON:0001821](http://purl.obolibrary.org/obo/UBERON_0001821) (sebaceous gland) and (not ([NCIT:C134672](http://purl.obolibrary.org/obo/NCIT_C134672) (Stage III Gallbladder Cancer AJCC v8))) 42.50%
- [UBERON:0001821](http://purl.obolibrary.org/obo/UBERON_0001821) (sebaceous gland) and (not ([NCIT:C134667](http://purl.obolibrary.org/obo/NCIT_C134667) (Stage II Gallbladder Cancer AJCC v8))) 42.50%
- [UBERON:0001821](http://purl.obolibrary.org/obo/UBERON_0001821) (sebaceous gland) and (not ([NCIT:C134665](http://purl.obolibrary.org/obo/NCIT_C134665) (Stage I Gallbladder Cancer AJCC v8))) 42.50%
- [UBERON:0001821](http://purl.obolibrary.org/obo/UBERON_0001821) (sebaceous gland) and (not ([NCIT:C134663](http://purl.obolibrary.org/obo/NCIT_C134663) (Stage 0 Gallbladder Cancer AJCC v8))) 42.50%
- [UBERON:0001821](http://purl.obolibrary.org/obo/UBERON_0001821) (sebaceous gland) and (not ([NCIT:C134523](http://purl.obolibrary.org/obo/NCIT_C134523) (Stage IV Hepatocellular Carcinoma AJCC v8))) 42.50%


